Applied DNA to Announce Second Quarter Fiscal 2025 Financial Results on May 15, Schedules Intra-Quarter Investor Update Call for June 3
Rhea-AI Summary
Applied DNA Sciences (NASDAQ:APDN) has announced it will release its Q2 FY2025 financial results on May 15, 2025, after U.S. market close. The company will file its Form 10-Q concurrently. Following its Annual Meeting of Stockholders on May 22, Applied DNA will host an intra-quarter investor update call on June 3, 2025, at 4:30 p.m. ET, where management will discuss strategic priorities.
The conference call will be accessible via multiple channels, including domestic (844-887-9402), international (412-317-6798), and Canadian (866-605-3852) dial-in numbers. A webcast replay will be available for 7 days following the call, with access codes provided for different regions.
Positive
- None.
Negative
- None.
News Market Reaction – APDN
On the day this news was published, APDN gained 5.62%, reflecting a notable positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
STONY BROOK, NY / ACCESS Newswire / May 14, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction (PCR)-based technologies, will release its financial results for the second quarter of fiscal year 2025 (ended on March 31, 2025) after the close of the U.S. equity markets on Thursday, May 15, 2025. The Company's Form 10-Q for the period will be filed concurrently and available on the SEC Filings page of its Investor Relations website.
To align with its Annual Meeting of Stockholders on May 22 and ensure a comprehensive post-meeting update, the Company will hold an intra-quarter investor update call on June 3, on which management will discuss the Company's strategic priorities.
Webcast and Conference Call Date & Time: Tuesday, June 3 @ 4:30 p.m. Eastern Time
Dial In:
Domestic callers (toll free): 844-887-9402
International callers: 412-317-6798
Canadian callers (toll free): 866-605-3852
Live webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=Ky09znsL
A replay of the conference call will be available for 7 days following the conclusion of the call:
Replay for domestic callers (toll free): 877-344-7529, replay access code 3446494
Replay for international callers: 412-317-0088, replay access code 3446494
Replay for Canadian callers (toll free): 855-669-9658, replay access code 3446494
An accompanying slide presentation will be embedded in the webcast (live and replay) that will also be accessible as a stand-alone document via the 'Company Presentations' page of the Applied DNA investor relations website. The webcast replay of the call will be available approximately one hour after the end of the call on the 'Company Events' page.
About Applied DNA Sciences
Applied DNA Sciences is a biotechnology company developing technologies to produce and detect deoxyribonucleic acid ("DNA"). Using the polymerase chain reaction ("PCR") to enable both the production and detection of DNA, we operate in two business markets: (i) the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and the development and sale of a proprietary RNA polymerase ("RNAP") for use in the production of mRNA therapeutics; and (ii) the detection of DNA and RNA in molecular diagnostics and genetic testing services.
Visit adnas.com for more information. Follow us on X and LinkedIn. Join our mailing list.
For additional information:
Investor Relations: Sanjay M. Hurry, 917-733-5573, sanjay.hurry@adnas.com
Web: https://investors.adnas.com/
###
SOURCE: Applied DNA Sciences
View the original press release on ACCESS Newswire
FAQ
When will Applied DNA (APDN) release its Q2 2025 earnings?
When is Applied DNA's (APDN) investor update call scheduled for Q2 2025?
How can I access Applied DNA's (APDN) Q2 2025 earnings call?
How long will the replay of Applied DNA's Q2 2025 earnings call be available?
